We are live on ! Find out more

1,470 hedge funds and large institutions have $103B invested in Merck in 2013 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 568 increasing their positions, 619 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 53

36% more call options, than puts

Call options by funds: $1.25B | Put options by funds: $918M

1.31% more ownership

Funds ownership: 76.5%77.81% (+1.3%)

1% more capital invested

Capital invested by funds: $102B → $103B (+$1.23B)

1% more funds holding

Funds holding: 1,4591,470 (+11)

8% less repeat investments, than reductions

Existing positions increased: 568 | Existing positions reduced: 619

3% less funds holding in top 10

Funds holding in top 10: 120117 (-3)

Holders
1,470
Holders Change
+11
Holders Change %
+0.75%
% of All Funds
47.65%
Holding in Top 10
117
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-2.5%
% of All Funds
3.79%
New
78
Increased
568
Reduced
619
Closed
53
Calls
$1.25B
Puts
$918M
Net Calls
+$331M
Net Calls Change
-$98.6M
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
326
Capstone Asset Management
Texas
$19.5M -$786K -17,215 -4%
CIA
327
CCM Investment Advisers
South Carolina
$19.3M +$642K +14,060 +3%
FT
328
Fiduciary Trust
Massachusetts
$19.2M +$320 +7 +0%
SCI
329
S&CO Inc
Massachusetts
$18.9M -$182K -3,995 -1%
N
330
Natixis
France
$18.8M +$18.5M +406,280 +4,825%
OC
331
Oppenheimer & Co
New York
$18.7M +$2.93M +64,131 +18%
PHS
332
PFM Health Sciences
California
$18.5M +$16.5M +360,613 +760%
BPBT
333
Boston Private Bank & Trust
Massachusetts
$18.4M -$163K -3,576 -0.9%
NB
334
Norinchukin Bank
Japan
$18.3M +$3.21M +70,306 +21%
FCBT
335
First Citizens Bank & Trust
North Carolina
$18.3M +$283K +6,191 +2%
OPERF
336
Oregon Public Employees Retirement Fund
Oregon
$18.2M +$220K +4,808 +1%
GI
337
GLG Inc
New York
$18.1M +$2.44M +53,446 +16%
ProShare Advisors
338
ProShare Advisors
Maryland
$18.1M -$11.1M -243,127 -38%
GKIM
339
GW&K Investment Management
Massachusetts
$17.9M -$2.68M -58,596 -13%
BF
340
BOK Financial
Oklahoma
$17.8M +$3.1M +67,939 +21%
MOACM
341
Mutual of America Capital Management
New York
$17.6M +$144K +3,150 +0.8%
KCM
342
Kornitzer Capital Management
Kansas
$17.5M -$33.5K -733 -0.2%
Truist Financial
343
Truist Financial
North Carolina
$17.4M -$3M -65,666 -15%
Zurich Cantonal Bank
344
Zurich Cantonal Bank
Switzerland
$17.4M +$1.24M +27,259 +8%
CC
345
Colrain Capital
Massachusetts
$17.3M -$3.22M -70,527 -16%
BCM
346
Bridgeway Capital Management
Texas
$17.3M +$443K +9,694 +3%
NEI
347
Northwest & Ethical Investments
Ontario, Canada
$17.2M -$105K -2,306 -0.6%
HPC
348
HM Payson & Co
Maine
$17.1M -$269K -5,883 -2%
BUB
349
BBVA USA Bancshares
Texas
$17.1M +$795K +17,415 +5%
BSA
350
Braun Stacey Associates
New York
$17M -$159K -3,491 -0.9%

MRK Hedge Fund Activity: Q3 2013 in Review

1,470 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2013, worth a combined $103B — up 1.2% from $102B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new MRK positions and 53 closed out — a net gain of 25 holders — while 568 added to existing stakes and 619 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $192M. The largest seller was Fidelity Investments, cutting an estimated $612M.

  • 1,470 institutional investors held Merck (MRK) as of Q3 2013, up from 1,459 in Q2 2013.
  • Funds reported $103B of Merck stock for Q3 2013, up 1.2% quarter-over-quarter.
  • 78 funds opened new Merck positions in Q3 2013 and 53 closed out, a net change of +25 holders.
  • The largest Merck buyer in Q3 2013 was Eagle Asset Management, an estimated $192M added.
  • The largest Merck seller in Q3 2013 was Fidelity Investments, an estimated $612M sold.

Based on aggregated 13F filings for Q3 2013.